Pennsylvania SB1196 ensures equal treatment of non-opioid and opioid drugs in Medicaid and commercial insurance.

Pennsylvania SB1196 amends the Human Services Code to establish pain parity in Medicaid and commercial insurance. It prohibits insurers from disadvantaging non-opioid drugs approved by the FDA for pain treatment in terms of coverage or cost-sharing compared to opioids. The bill also mandates that the Department of Human Services not disadvantage non-opioid drugs in Medicaid by imposing more restrictive controls or higher cost-sharing than opioids. This applies to all non-opioid drugs approved by the FDA for pain management.

Pennsylvania SB1196 ensures equal treatment of non-opioid and opioid drugs in Medicaid and commercial insurance.

Pennsylvania SB1196 amends the Human Services Code to establish pain parity in Medicaid and commercial insurance. It prohibits insurers from disadvantaging non-opioid drugs approved by the FDA for pain treatment in terms of coverage or cost-sharing compared to opioids. The bill also mandates that the Department of Human Services not disadvantage non-opioid drugs in Medicaid by imposing more restrictive controls or higher cost-sharing than opioids. This applies to all non-opioid drugs approved by the FDA for pain management.